Biotech company Modern Meadow promoted Catherine Roggero-Lovisi to serve as its new chief executive officer, effective Sept. 1.
Elevated from her role as president and chief operating officer, Roggero-Lovisi succeeds Anna Bakst, who will continue to serve as executive chair on the company’s board of directors, according to a Sept. 7 announcement from the Nutley-based company.
In her new role, Roggero-Lovisi is responsible for furthering the company’s commercial development, enabling technology-focused partnerships, and reaffirming its commitment to a global shift toward a more sustainable bioeconomy.
Roggero-Lovisi has more than 20 years of executive experience, including in roles at L’Oréal, Revlon and Christian Louboutin.
“Catherine brings a wealth of experience and knowledge across the global retail and consumer goods landscape, as well as a vast network of strategic relationships,” Bakst said in a statement. “For the past 12 months, we have had the privilege of experiencing Catherine’s inspiring leadership and commitment to the values we hold dear at Modern Meadow, using scientific innovation to solve real-world problems.”
Roggero-Lovisi added, “I believe we have an exciting future in front of us, and I look forward to working alongside our board, leadership, associates, and partners to continue to fuel the next decade of sustainable innovation and to bring more of Modern Meadow’s high-performing products to market for real-world impact.”
Modern Meadow’s proprietary technologies, including its Bio-Alloy and Bio-F@rm application platforms, offer alternatives to petrochemical and animal-derived materials and can be used by textiles, beauty and other industries.